| 000 | 01415 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250514225226.0 | ||
| 264 | 0 | _c20050630 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0891-3668 | ||
| 024 | 7 |
_a10.1097/01.inf.0000164162.00163.9d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaplan, Sheldon L | |
| 245 | 0 | 0 |
_aTreatment of community-associated methicillin-resistant Staphylococcus aureus infections. _h[electronic resource] |
| 260 |
_bThe Pediatric infectious disease journal _cMay 2005 |
||
| 300 |
_a457-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aClindamycin _xtherapeutic use |
| 650 | 0 | 4 |
_aCommunity-Acquired Infections _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdiagnosis |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use |
| 773 | 0 |
_tThe Pediatric infectious disease journal _gvol. 24 _gno. 5 _gp. 457-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.inf.0000164162.00163.9d _zAvailable from publisher's website |
| 999 |
_c15540390 _d15540390 |
||